CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: Relevance to psoriasis

Experimental Dermatology

Volumn 20, Issue 8, 2011, Pages 627-632

  Litvinov, Ivan V ^a   Bizet, Albane A ^a   Binamer, Yousef ^a   Jones, David A ^b   Sasseville, Denis ^a   Philip, Anie ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD109; Psoriasis; STAT3 and glycosyl phosphatidylinositol anchored proteins; TGF

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MESSENGER RNA; PROTEIN CD109; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL SURFACE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PSORIASIS; SIGNAL TRANSDUCTION;

ANTIGENS, CD; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; GPI-LINKED PROTEINS; HUMANS; KERATINOCYTES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PSORIASIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 79960287248     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01288.x     Document Type: Article

References (49)

1. Huerta C, Rivero E, Rodriguez L A. Arch Dermatol 2007: 143: 1559-1565.
2. Nestle F O, Kaplan D H, Barker J. N Engl J Med 2009: 361: 496-509.
3. Albanesi C, De Pita O, Girolomoni G. Clin Dermatol 2007: 25: 581-588.
4. Nickoloff B J, Bonish B K, Marble D J et al. J Investig Dermatol Symp Proc 2006: 11: 16-29.
5. Werner S, Krieg T, Smola H. J Invest Dermatol 2007: 127: 998-1008.
6. Shipley G D, Pittelkow M R, Wille J J Jr et al. Cancer Res 1986: 46: 2068-2071.
7. Shirakata Y. J Dermatol Sci 2010: 59: 73-80.
8. Schmierer B, Hill C S. Nat Rev Mol Cell Biol 2007: 8: 970-982.
9. Shi Y, Massague J. Cell 2003: 113: 685-700.
10. Rahimi R A, Leof E B. J Cell Biochem 2007: 102: 593-608.
11. Reiss M, Sartorelli A C. Cancer Res 1987: 47: 6705-6709.
12. Glick A B, Kulkarni A B, Tennenbaum T et al. Proc Natl Acad Sci U S A 1993: 90: 6076-6080.
13. Sellheyer K, Bickenbach J R, Rothnagel J A et al. Proc Natl Acad Sci U S A 1993: 90: 5237-5241.
14. Flisiak I, Chodynicka B, Porebski P et al. Cytokine 2002: 19: 121-125.
15. Nockowski P, Szepietowski J C, Ziarkiewicz M et al. Acta Dermatovenerol Croat 2004: 12: 2-6.
16. Han G, Williams C A, Salter K et al. J Invest Dermatol 2010: 130: 371-377.
17. Li A G, Wang D, Feng X H et al. EMBO J 2004: 23: 1770-1781.
18. Michaelis K, Wallbrecht K, Kerstan A et al. Exp Dermatol 2010: 19: 406-415.
19. Finnson K W, Tam B Y, Liu K et al. FASEB J 2006: 20: 1525-1527.
20. Tam B Y, Finnson K W, Philip A. J Biol Chem 2003: 278: 49610-49617.
21. Tam B Y, Philip A. J Cell Physiol 1998: 176: 553-564.
22. Lin M, Sutherland D R, Horsfall W et al. Blood 2002: 99: 1683-1691.
23. Bizet A, Finnson K, Liu K et al. Wound Repair Regen 2007: 15: A26-A26.
24. Bizet A A, Liu K, Tran-Khanh N et al. J Invest Dermatol 2009: 129: S94-S94.
25. Tam B Y, Larouche D, Germain L et al. J Cell Biochem 2001: 83: 494-507.
26. Hagiwara S, Murakumo Y, Sato T et al. Cancer Sci 2008: 99: 1916-1923.
27. Boukamp P, Petrussevska R T, Breitkreutz D et al. J Cell Biol 1988: 106: 761-771.
28. Dickson M A, Hahn W C, Ino Y et al. Mol Cell Biol 2000: 20: 1436-1447.
29. Litvinov I V, Antony L, Dalrymple S L et al. Prostate 2006: 66: 1329-1338.
30. Guda K, Natale L, Markowitz S D. Cytotechnology 2007: 54: 85-88.
31. Litvinov I V, Vander Griend D J, Xu Y et al. Cancer Res 2006: 66: 8598-8607.
32. Jones D A, Yawalkar N, Suh K Y et al. J Invest Dermatol 2004: 123: 93-100.
33. Litvinov I V, Jones D A, Sasseville D et al. Clin Cancer Res 2010: 16: 2106-2114.
34. Senoo M, Pinto F, Crum C P et al. Cell 2007: 129: 523-536.
35. Sano S, Chan K S, Carbajal S et al. Nat Med 2005: 11: 43-49.
36. Sano S, Chan K S, DiGiovanni J. J Dermatol Sci 2008: 50: 1-14.
37. Sano S, Chan K S, Kira M et al. Cancer Res 2005: 65: 5720-5729.
38. Alvarez J V, Frank D A. Cancer Biol Ther 2004: 3: 1045-1050.
39. Grad J M, Zeng X R, Boise L H. Curr Opin Oncol 2000: 12: 543-549.
40. Hodge D R, Hurt E M, Farrar W L. Eur J Cancer 2005: 41: 2502-2512.
41. Rosenblum M L, Dougherty D V, Deen D F et al. Cancer Treat Rep 1981: 65 (Suppl 2): 61-66.
42. Rosenblum M L, Knebel K D, Wheeler K T et al. In Vitro 1975: 11: 264-273.
43. Matsuura H, Myokai F, Arata J et al. J Dermatol Sci 1994: 8: 25-32.
44. Venneker G T, Das P K, Meinardi M M et al. J Pathol 1994: 172: 189-197.
45. Kocak M, Bozdogan O, Erkek E et al. Int J Dermatol 2003: 42: 789-793.
46. Wrone-Smith T, Johnson T, Nelson B et al. Am J Pathol 1995: 146: 1079-1088.
47. Malkani A K, Baker B S, Garioch J J et al. Exp Dermatol 1993: 2: 224-230.
48. Jagadeesan J, Bayat A. Int J Surg 2007: 5: 278-285.
49. Varga J, Pasche B. Nat Rev Rheumatol 2009: 5: 200-206.